Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

Obesity pipeline

Drugs

Every obesity program in this file, grouped by class. Open a drug for its studies and the sources behind each figure.

ClassNone selected
MechanismNone selected
Route

A route is listed here when at least one program uses it. The full list is on Methods. Unknown means the source did not name a route.

All programs shown

94 of 94 programs shown

GLP-1 RA 17 drugs

GLP-1/GIP 7 drugs

GLP-1/glucagon 4 drugs

GIP/GLP-1/glucagon 2 drugs

  • RetatrutideEli LillyPhase 3subcutaneous13 studiesGIP/GLP-1/glucagon
  • UBT251The United Bio-Technology (Hengqin) CoPhase 3subcutaneous8 studiesGIP/GLP-1/glucagon

Amylin combo 1 drug

Oral small molecule 7 drugs

GLP-1 conjugate 1 drug

Amylin 6 drugs

Myostatin/activin 3 drugs

MC4R 1 drug

CB1 2 drugs

Lipase inhibitor 1 drug

  • OrlistatXenicalEmpros Pharma ABApprovedoral12 studiesLipase inhibitor

Opioid and antidepressant 1 drug

Sympathomimetic combo 1 drug

Monoamine reuptake 2 drugs

  • SibutramineAbbottPhase 3oral8 studiesMonoamine reuptake
  • TesofensineNeuroSearchPhase 2daily4 studiesMonoamine reuptake

SARM 1 drug

Class not reported 34 drugs

MetAP2 inhibitor 1 drug

  • BeloranibZafgenPhase 3subcutaneous6 studiesMetAP2 inhibitor

Serotonin agonist 1 drug

Small molecule 1 drug

  • MDR-001MindRank AI LtdPhase 3oral4 studiesSmall molecule